Powder: -20°C for 3 years | In solvent: -80°C for 1 year
QNZ (EVP4593) (EVP4593) is an effective inhibitor of NF-κB activation and TNF-α production. The IC50 of QNZ for NF-κB and TNF-α is11 nM and 7 nM, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 36.00 | |
2 mg | In stock | $ 52.00 | |
5 mg | In stock | $ 85.00 | |
10 mg | In stock | $ 143.00 | |
25 mg | In stock | $ 238.00 | |
50 mg | In stock | $ 347.00 | |
100 mg | In stock | $ 516.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 94.00 |
Description | QNZ (EVP4593) (EVP4593) is an effective inhibitor of NF-κB activation and TNF-α production. The IC50 of QNZ for NF-κB and TNF-α is11 nM and 7 nM, respectively. |
Targets&IC50 | TNF-α:7 nM |
Synonyms | CAY10470, EVP4593 |
Molecular Weight | 356.42 |
Formula | C22H20N4O |
CAS No. | 545380-34-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 5 mg/mL (14.02 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
QNZ 545380-34-5 Apoptosis NF-Κb TNF NF-κB TNFR CAY-10470 EVP-4593 Inhibitor Nuclear factor-kappaB CAY10470 EVP 4593 inhibit Tumor Necrosis Factor Receptor Nuclear factor-κB CAY 10470 TNF Receptor EVP4593 inhibitor